Immunitybio (IBRX) had the lowest return between January 1, 2023 and March 31, 2023 by a US stock with a market cap of $2B+, returning -64.9%.
| ASSET | DATE | % RETURN |
|---|---|---|
Immunitybio (IBRX) | 1/1/2023 - 3/31/2023 | -64.86% |
Summit Therapeutics (SMMT) | 1/1/2023 - 3/31/2023 | -59.68% |
D-Wave Quantum (QBTS) | 1/1/2023 - 3/31/2023 | -55.73% |
Xometry (XMTR) | 1/1/2023 - 3/31/2023 | -53.64% |
National Vision (EYE) | 1/1/2023 - 3/31/2023 | -52.17% |
Lumen Technologies (LUMN) | 1/1/2023 - 3/31/2023 | -50% |
Alignment Healthcare LLC (ALHC) | 1/1/2023 - 3/31/2023 | -46.69% |
VNET Group Inc DRC (VNET) | 1/1/2023 - 3/31/2023 | -43.16% |
Western Alliance Bancorporation (WAL) | 1/1/2023 - 3/31/2023 | -40.35% |
Rhythm Pharmaceuticals (RYTM) | 1/1/2023 - 3/31/2023 | -39.48% |
Zions Bancorporation (ZION) | 1/1/2023 - 3/31/2023 | -38.03% |
Arrowhead Pharmaceuticals (ARWR) | 1/1/2023 - 3/31/2023 | -37.75% |
Charles Schwab (SCHW) | 1/1/2023 - 3/31/2023 | -37.13% |
CVB Financial (CVBF) | 1/1/2023 - 3/31/2023 | -35.45% |
Customers Bancorp (CUBI) | 1/1/2023 - 3/31/2023 | -35.02% |
Hesai Group American Depositary Share, each ADS represents one Class B ordinary share (HSAI) | 1/1/2023 - 3/31/2023 | -34.86% |
Dave (DAVE) | 1/1/2023 - 3/31/2023 | -34.7% |
Comerica (CMA) | 1/1/2023 - 3/31/2023 | -34.34% |
WM Technology (MAPSW) | 1/1/2023 - 3/31/2023 | -34.18% |
BankUnited (BKU) | 1/1/2023 - 3/31/2023 | -33.71% |
Halozyme Therapeutics (HALO) | 1/1/2023 - 3/31/2023 | -32.99% |
Bank of Hawaii (BOH) | 1/1/2023 - 3/31/2023 | -32.59% |
United Natural Foods (UNFI) | 1/1/2023 - 3/31/2023 | -32.49% |
Amneal Pharmaceuticals, Inc Class A Common Stock (AMRX) | 1/1/2023 - 3/31/2023 | -32.2% |
Ondas (ONDS) | 1/1/2023 - 3/31/2023 | -32.08% |
